James Shields joins Spectrum
This article was originally published in Scrip
Executive Summary
Spectrum Pharmaceuticals, a US biotechnology company focused on oncology and haematology, has appointed James Shields senior vice-president and chief commercial officer. He has previously served as vice-president of sales for oncology and injectable products for MGI Pharmaceuticals, and as vice-president of sales and marketing of oncology for Supergen. He was most recently at Teva Pharmaceutical Industries, and has also worked for Centocor, Bristol-Myers Squibb, ICI and Stuart Pharmaceuticals.